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We estimated the influence of plasmids with DNA carrying the neurotrophin-3 (NT-3) gene 
on apoptosis in the gastrocnemius muscle and content of  Ca2+-ATPase in the latter after 
sciatic nerve injury. Sixty adult Wistar rats were randomly divided into the saline (control) 
and NT-3 groups. The related indices, such as expression of caspase-3 protein, the rate of 
apoptosis in the muscle evaluated using a TUNEL technique, and the level of Ca2+-ATPase 
estimated using Western blot, were observed. Expression of caspase-3 protein was elevated 
at different post-operative times after peripheral nerve injury; NT-3 expression and the rate 
of muscle cell apoptosis decreased, whereas the level of Ca2+-ATPase in the sarcoplasmic 
reticulum increased; significant differences were observed compared with the saline group (P 
< 0.05). The mitigation mechanism of NT-3 on muscle atrophy after peripheral nerve injury is 
expressed as inhibition of caspase-3 gene expression, increase in the Ca2+-ATPase level, and 
reduction in the rate of muscle apoptosis.
Keywords: neurotrophin-3, peripheral nerve injury, muscle cell apoptosis, caspase-3, 
Ca2+-ATPase.
1 First Affiliated Hospital of the Xinxiang Medical University, Weihui, China.
Correspondence should be addressed to Yu. Dong
(e-mail: yuzhendongcnx@126.com). 
INTRODUCTION
Skeletal muscles suffer from muscle atrophy after 
peripheral nerve injury because loss of the nutritional 
support and wasting of the nerves, which severely 
affect the recovery of the limb function [1]. Previous 
experimental studies showed that passive exercise, 
medication, and implantation of sensory neurons, as 
well as some other measures, can prevent skeletal 
muscle denervation-related  atrophy to a considerable 
extent; however, the experience of the respective 
clinical applications is limited [2-4]. Muscle apoptosis 
is a major cause of irreversible denervation-related 
atrophy. Apoptosis can be inhibited and muscle 
atrophy can be mitigated by early intervention or 
effective treatments before neurological recovery; 
this is a central approach in treating  the results of 
peripheral nerve injury [5, 6].
Muscle apoptosis is irreversible programmed cell death 
induced by intracellular calcium overloading, excess of 
free radicals, microcirculation obstruction, and some other 
reasons. Moreover, apoptosis-related expression of protein 
products of a few genes, such as caspase, Bcl-2, and p53, 
also intensifies muscle apoptosis [7, 8]. 
Many experimental results showed that the secretion 
of neurotrophic factors is reduced after peripheral 
nerve injury, and an exogenous neurotrophic factor 3 
(neurotrophin 3, NT-3) promotes nerve regeneration 
and protects against muscle atrophy [9, 10]. However, 
the mechanism of such effects remains unclear. 
Therefore, we used NT-3 in the experiment to treat 
rats in a sciatic nerve injury model. The respective 
indicators, such as caspase-3 expression, rate of 
muscle cell apoptosis, and Ca2+-ATPase level acting 
on excitation-contraction coupling, were observed. 
The protective mechanism of the effects of NT-3 on 
the nerve post injury repairment and on the prevention 
of muscle atrophy has been discussed.
METHODS
Animal Model and Grouping. Sixty healthy Wistar 
rats provided by the Experimental Animal Center of the 
Xinxiang Medical University were used. These were 
males and females, with the body mass of 200 to 250 g 
(animal license number 2008-0001 of SCXK, Henan). 
The animals were anaesthetized by i.p. injection of 2% 
sodium pentobarbital (30 mg/kg). The sciatic nerves 
were exposed under an operation microscope, cut 
off at 2 cm from the sciatic nerve exit, and sutured 
NEUROPHYSIOLOGY / НЕЙРОФИЗИОЛОГИЯ.—2015.—T. 47, № 6 521
EFFECTS OF NEUROTROPHIN-3 PLASMIDS ON MYOCYTE APOPTOSIS
into the surrounding muscles around the proximal 
back. Distal ends of the nerves were ligated with a 
10-0 microscopic suture. After random grouping, saline 
or a solution containing 2 µl of plasmid DNA carrying 
gene NT-3 (concentration 1 µg/µl) were injected into 
the m. gastrocnemius using a microsyringe (plasmid 
DNA was synthesized and purified by the Beijing 
Parkson Biological Engineering, China). The injection 
needles were held for 2 min. All animals were routinely 
reared separately after the operation.
Expression of Caspase-3. Gastrocnemius total 
RNA was extracted under anaesthesia at post-
operative times of 2, 4, or 8 h and 1, 3, 7, 14, or 
21 days (d), using the cell protein extraction kit (Sigma, 
USA), and then amplified by a PCR reaction system 
for gel electrophoresis. Caspase-3 primer sequences 
(a caspase-3 upstream primer, 5’-AA G AA G ACC A 
TA GCA AAA GGA, and a downstream G-3’ primer, 
5’-CAC AAA GTG ACT GGA TGA ACC-3’, 
an internal reference β-actin upstream primer, 
5’-CCA A GG CCA ACCGCG AG-AA GA TG AC-3’, 
and a downstream primer, 5’-A GGGTA CA T 
GGT GGT GCC GCC A GA C-3’), were used. The 
gastrocnemius muscle was paraffin-embedded and 
sectioned. Caspase-3 antibody was used for staining; 
slices were mounted and observed under a light 
microscope. Then, the slices were treated with 50 μl 
of 10% goat serum (25°C) for 30 min, with 50 μl of 
caspase-3 rabbit polyclonal antibody (concentration 
1:200) overnight at 4°C, and with 50 μl of secondary 
antibody (concentration of 1:150) for 20 min at 25°C. 
This was followed by incubation with 50 μl of HRP-
labelled streptavidin for 10 min (25°C). The slices 
were diaminobenzidine-coloured and hematoxylin-
restained; the cyto-immunoplasm of positive units 
appeared brown-coloured. The caspase-3 protein 
expression was determined by TJTY-300 Image 
Analysis software.
Detection of Apoptosis in the M. Gastrocnemius. 
Denervated gastrocnemius specimens were collected 
from each group, and paraffin 5-µm-thick sections 
were prepared at post-operative 1, 4, and 8 weeks. 
Fluorescent TUNEL assay was used to detect cell 
apoptosis, in strict accordance with the instructions 
of the TUNEL in situ apoptosis detection kit (Boster 
Biological Engineering, China). The labelled positive 
nuclei were brownish-yellow. The 10 selected non-
repeated fields of vision were obtained from each 
slice to count positive cells, and the rate of apoptosis 
(positive nuclei/total nuclei number ∙ 100%) was 
calculated. Average values were obtained for each 
calculation.
Western Blot. Similar amounts of protein in the 
gastrocnemius muscle samples were obtained 1, 2, 4, 6, 
and 8 weeks after operation using gel electrophoresis 
(Sigma, USA). The proteins were closed using 
25 ml of blocking solution for 1 h at room temperature. 
After the film was transferred, the first antibody was 
added (incubation for 3 h). Subsequently, horseradish 
peroxidase-labelled secondary antibody was added, 
tableted, and punched. The expression of Ca2+-ATPase 
was detected using the corresponding chemical system.
Statistical Analysis. SPSS 13.0 software was used 
for statistical analysis. Results are expressed below as 
means ± s.d. Mean values were compared between the 
two experimental groups using the two-sample t-test. 
Differences with P < 0.05 were considered statistically 
significant.
RESULTS
Caspase-3 Gene Expression. The expression changes 
after amplification of the products of caspase-3 gene 
were subjected to agarose gel electrophoresis. The 
products inserted by NT-3 gene fragments were recycled 
from hard gel, and the recovery product sequence was 
verified by restriction of enzyme digestion, showing 
clear bands of each target gene and internal reference 
standard (Fig. 1).
F i g. 1. Caspase-3 expression in the saline control 
group (A) and NT-3 group (B). 
Р и с. 1. Експресія каспази-3 у контрольній 
групі (А) та групі NT-3 (B).
A
B
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Caspase-3 protein expression somewhat increased 
2 h after injury, but with no significant difference 
between the control and experimental groups 
(P > 0.05). The expression continuously increased over 
time. Meanwhile, the growth rate gradually declined 
at post-operation d7. From h4, caspase-protein 
expression in the NT-3 group became significantly 
lower (P < 0.05) than that in the control group (Table 1; 
Fig. 2).
Apoptosis Rate. Muscle cell apoptosis was 
observed after one week in both groups with no 
significant intergroup difference (P > 0.05). The 
intensity of apoptosis significantly increased in the 
control group in 4 and 8 weeks post-operation. The 
irregular-shape cells appeared shrinked and exhibit- 
ed a wrinkled nuclear membrane. Brown particles 
were also observed in the nucleus. Meanwhile, the 
numbers of positive cells in the NT-3 group were 
significantly smaller than in the control (Fig. 3). 
The gastrocnemius apoptosis rates in the two groups 
4 and 8 weeks post-operation were 32.09 ± 1.02 vs. 
19.84 ± 0.63% and 41.67 ± 1.48 vs. 13.83 ± 0.25%, 
respectively. The means within the groups differed 
from each other statistically significantly (P < 0.05).
Changes in the Ca2+-ATPase Content in the 
M. Gastrocnemius. Ca2+-ATPase expression in the 
muscle detected in the two groups was measured at 
postoperative weeks 1, 2, 4, 6, and 8 after peripheral 
nerve injury. The Ca2+-ATPase levels in the control 
group at weeks 1 and 2 did not significantly differ from 
those in the NT-3 group. After 4, 6 and 8 weeks, the 
enzyme expression in the NT-3 group was significantly 
greater compared with that in the control group 
(P < 0.05).
F i g. 2. Caspase-3 expression observation on day 21 (×200). A) Control group; B) NT-3 group.
Р и с. 2. Експресія каспази-3 на 21-й день у контрольній групі (А) та групі NT-3 (B). 
A
A
B
B
F i g. 3. Observation of TUNEL-visualized muscle cell apoptosis on week 8 (×400). A) Control group; B) NT-3 group.
Р и с. 3. Візуалізація апоптозу м’язових клітин на восьмий тиждень у контрольній групі (А) та групі NT-3 (B).
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DISCUSSION
The skeletal muscle loses afferent nerve impulsation 
and control after peripheral nerve injury, and this 
results in muscle atrophy because of the absence/ 
decrease of neurotrophic factors in target cells. 
Mikhail et al. [11, 12] found that NT-3 levels were 
reduced within a 6 to 12 h interval after peripheral 
nerve injury. After two weeks, the respective group 
exhibited NT-3 levels eight times higher than that in 
the control group. Administration of exogenous NT-3 
could promote growth of neuronal axons and myelin, 
thus maintaining afferent sensory neuronal survival 
of muscle spindles, tendon receptors, and cutaneous 
receptors, as well as promoting maturation of nerve-
muscle synapses and significantly delaying the effect 
of skeletal muscle atrophy after nerve injury. However, 
the exact mechanism of the action of NT-3 has not 
been examined sufficiently and remains unclear.
Experimental results showed that Trk C is a specific 
receptor of NT-3, which can achieve the expression 
of its own signal molecules, such as neuronal Ca2+ 
channels and neurotransmitter receptors, and regulate 
the functional state through rapid starting of a series 
of signal transduction pathways. It promotes the 
function of Ca2+-ATPase and prevents atrophy of 
denervated skeletal muscles [12, 13]. Ca2+-ATPase 
is the major protein involved in the regulation of 
Ca2+ in the sarcoplasmic reticulum and cytoplasm, 
thus forming the basis for contraction and relaxation 
of skeletal muscle fibers [14, 15]. Peripheral nerve 
injury induces an energy deficiency of Ca2+-ATPase 
in the skeletal muscle, in such a way decreasing the 
absorption capacity for Ca2+. Moreover, a large amount 
of intracellular and mitochondrial Ca2+ is accumulated, 
which results in a decreased contractility of the 
skeletal muscle; the respective mechanism, however, 
remains unclear to great extent [16].
Our study showed that the level of gastrocnemius 
Ca2+-ATPase decreased significantly one week after 
denervation, sarcoplasmic Ca2+-ATPase increased 
significantly in the NT-3-treated group (as compared 
with that in the former group), and the contractile 
function of the denervated skeletal muscle significantly 
increased compared with those in the control group. 
Findlay et al. [17] reported that NT-3 mRNA in a 
denervated skeletal muscle is downregulated. NT-3 
was found to enhance the formation and promote the 
development of neuromuscular synapses. Regeneration 
in a mixed culture after NT-3 was locally injected into 
muscle cells in vitro was intensified, thus preventing 
the effects of muscle atrophy. Sahenk et al. [18] proved 
that NT-3 is abundant in skeletal muscles. Local 
endogenous injection can enhance RNA expression in 
advance, stimulate proliferation of myoblasts, promote 
the formation of muscle tube fuse into muscle fibers, 
and accelerate the repair process in the skeletal muscle.
It was found that increased caspase-3 expression 
is involved in the regulation of apoptosis after spinal 
cord injury. Caspase-3 was the most important 
protease involved in the above process. NT-3 may 
inhibit transcription of the caspase-3 gene, reduce pro-
apoptotic factors, and inhibit in such a way neuronal 
apoptosis [19, 20]. However, many other apoptosis-
related proteins, such as the Bcl-2 family and P53 
protein, were found [21, 22]. Our experiments showed 
that caspase-3 gene transcription and the respective 
protein expression level began to increase 2 h after 
nerve injury. However, caspase-3 gene transcription in 
the NT-3 group appeared to be significantly lower at 
4 h, whereas the caspase-3 level in the control group 
remained continuously high (differences between the 
two groups were statistically significant; P < 0.05). 
After application of exogenous NT-3 for 1 week, no 
muscle cell apoptosis was observed in both control and 
NT-3 experimental groups, and differences between 
the gastrocnemius apoptotic rates in the 4 and 8 week 
groups were significant (P < 0.05).
In our study, caspase-3 gene expression was 
higher, anti-apoptotic factors were lacking, and 
the Ca2+-ATPase level decreased after nerve injury, 
which was the major cause of muscle cell apoptosis. 
Caspase-3 mRNA and protein expression increased 
the proliferative capacity of skeletal muscle cells by 
T a b l e 1. Expression of caspase-3 protein in two experimental groups (x ± s.e.m.). 
Т а б л и ц я 1. Експресія протеїну каспази-3 в двох експериментальних групах.
Group h2 h4 h8 d1 d7 d14 d21
Control 0.427±0.031 0.514±0.036 0.574±0.039 0.636±0.045 0.712±0.051 0.830±0.069 0.941±0.0075
NT-3 0.438±0.030 0.473±0.034* 0.506±0.037* 0.540±0.041* 0.608±0.046* 0.581±0.047* 0.460±0.037*
Footnotes: Caspase-3 protein expression in the two groups began to rise 2 h after injury; the intergroup difference at h2 was statistically 
insignificant (P > 0.05). Caspase-3 protein expression of the NT-3 group demonstrated statistically significant differences from h4 after 
operation compared with that in the control group (P < 0.05).
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NT-3 exogenous intervention, Subsequently, the Ca2+-
ATPase content increased (promoting skeletal muscle 
contraction and, thereby, reducing the pro-apoptotic 
factors and inhibiting muscle apoptosis). As a result, 
post-denervation muscle atrophy was inhibited, and 
nerve regeneration was promoted. However, muscle 
atrophy still remained significant despite a sufficient 
amount of exogenous NT-3. Thus, the lack of 
neurotrophic factors was not the only cause of muscle 
atrophy. A search for other reasons and mechanisms of 
muscle atrophy will be the aim of our future studies.
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Р е з ю м е
Ми вивчали вплив плазмід із ДНК, що несе ген нейротрофі-
ну-3 (NT-3), на апоптоз міоцитів у m. gastrocnemius та вміст 
Ca2+-ATФази в цьому м’язі після перерізання сідничного 
нерва. 60 дорослих щурів лінії Вістар були рандомізовано 
поділені на контрольну (введення фізіологічного розчину) 
та NT-3-групи. Оцінювали відповідні показники – експре-
сію протеїну каспази-3, рівень апоптозу в м’язі (з викорис-
танням TUNEL-методики) та рівень Ca2+-ATФази (з вико-
ристанням Вестерн-блотингу). Експресія білка каспази-3 в 
різні часові інтервали після пошкодження периферичного 
нерва була підвищеною; експресія NT-3 та рівень апоптозу 
м’язових клітин були знижені, а вміст Ca2+-ATФази в сарко-
плазматичному ретикулумі – підвищеним. Відмінності цих 
показників щодо таких у контрольній групі були вірогідни-
ми (P < 0.05). Обмежуючі впливи NT-3 на процес м’язової 
атрофії після пошкодження периферичного нерва виявля-
лись як інгібування експресії гена каспази-3, підвищення 
вмісту Ca2+-ATФази та зниження інтенсивності апоптозу в 
м’язі.
REFERENCES
1 A. S. Brack, M. J. Conboy, S. Roy, et al., “Increased Wnt 
signaling during aging alters muscle stem cell fate and 
increases fibrosis,” Science, 317, 807-810 (2007).
2 W. Song, H. B. Kwak, and J. M. Lawler, “Exercise training 
attenuates age-induced changes in apoptotic signaling in rat 
skeletal muscle,” Antioxid. Redox Signal., 8, 517-528 (2006).
3 L. S. Nierobisz, B. Cheatham, B. M. Buehrer, and J. Z. Sexton, 
“High-content screening of human primary muscle satellite 
cells for new therapies for muscular atrophy/dystrophy,” Curr. 
Chem. Genomics Transl. Med., 7, 21-29 (2013).
4 B. T. Bennett, J. S. Mohamed, and S. E. Always, “Effects of 
resveratrol on the recovery of muscle mass following disuse 
in the plantaris muscle of aged rats,” PLoS One, 8, e83518 
(2013). 
5 K. Kaori, Y. Dai, E. Karla, et al., “Caspase-mediated protein 
kinase C cleavage is necessary for apoptosis of vascular 
smooth muscle cells,” Am. J. Physiol. Heart Circ. Physiol., 
297, 2253-2261 (2009).
6 B. Sishi, B. Loos, B. Ellis, et al., “Diet-induced obesity 
alters signalling pathways and induces atrophy and apo- 
ptosis in skeletal muscle in a prediabetic rat model,” Exp. 
Physiol., 96, 179-193 (2011). 
7 Q. Chen, L. Zhou, and H. D. Shine, “Expression of 
neurotrophin-3 promotes axonal plasticity in the acute but 
not chronic injured spinal cord,” J. Neurotrauma, 23, 1254-
1260 (2006).
8 J. R. Mendell, L. Rodino-Klapac, Z. Sahenk, et al., “Gene 
therapy for muscular dystrophy: lessons learned and path 
forward,” Neurosci. Lett., 527, 90-99 (2012).
9 T. Hag, K. A. Baker, J. G. Emsley, et al., “Prolonged local 
neurotrophin-3 infusion reducs ipsilateral collateral sprout- 
ing of spared corticospinal axons in adult rats,” Neuroscience, 
130, 875-887 (2005).
10 W. Zhang, Y. Miao, Z. Xing, et al., “Growth-associated 
protein-43 expression in cocultures of dorsal root ganglion 
neurons and skeletal muscle cells with different neurotrophins,” 
Muscle Nerve, 47, 909-915 (2013).
11 A. K. Mikhail, S. Rachid, R. Khadija, et al., “Pleiotropic 
effects of neutrophils on myocyte apoptosis and left ventricular 
remodeling during early volume overload,” J. Mol. Cell. 
Cardiol., 47, 634-645 (2009). 
12 S. A. Kulakowski, S. D. Parker, and K. E. Personius, “Reduced 
TrkB expression results in precocious age-like changes in 
neuromuscular structure, neurotransmission, and muscle 
function,” J. Appl. Physiol., 111, 844-852 (2011).
13 S. Lin, J. Xu, S. Hu, et al., “Combined application of 
neutrophin-3 gene and neural stem cells is ameliorative to 
delay of denervated skeletal muscular atrophy after tibial nerve 
transection in rats,” Cell Transplant., 20, 381-390 (2011).
14 J. H. Hsieh, W. M. Lin, H. Chiang, et al., “Patterns of target 
tissue reinnervation and trophic factor expression after 
nerve grafting,” Plast. Reconstr. Surg., 131, 989-1000 (2013).
15 W. Wang, H. Zhang, H. Gao, et al., “β
1
-Adrenergic receptor 
NEUROPHYSIOLOGY / НЕЙРОФИЗИОЛОГИЯ.—2015.—T. 47, № 6 525
EFFECTS OF NEUROTROPHIN-3 PLASMIDS ON MYOCYTE APOPTOSIS
activation induces mouse cardiac myocyte death through 
both L-type calcium channel-dependent and independent 
pathways,” Am. J. Physiol. Heart Circ. Physiol., 299, 322-331 
(2010).
16 S. Suzuki, U. Yokoyama, T. Abe, et al., “Differential roles 
of epac in regulating cell death in neuronal and myocar- 
dial cells,” J. Biol. Chem., 285, 24248-24259 (2010).
17 A. R. Findlay, S. Lewis, Z. Sahenk, and K. M. Flanigan, 
“Camptocormia as a late presentation in a manifesting 
carrier of duchenne muscular dystrophy,” Muscle Nerve, 47, 
124-127 (2013).
18 Z. Sahenk, G. Galloway, K. R. Clark, et al., “aav1.nt-3 gene 
therapy for Charcot-Marie tooth neuropathy,” Mol. Ther., 22, 
511-521 (2014).
19 T. T. Tzeng, H. J. Tsay, L. Chang, et al., “Caspase 3 involves 
in neuroplasticity, microglial activation and neurogenesis 
in the mice hippocampus after intracerebral injection of kainic 
acid,” J. Biomed. Sci., 20, 90 (2013).
20 S. Zhu, M. Nagashima, M. A. Khan, et al., “Lack of caspase-3 
attenuates immobilization-induced muscle atrophy and loss 
of tension generation along with mitigation of apoptosis 
and inflammation,” Muscle Nerve, 47, 711-721 (2013).
21 H. R. Momeni, M. S. Mehranjani, M. A. Shariatzadeh, and 
M. Haddadi, “Caspase-mediated apoptosis in sensory neurons 
of cultured dorsal root ganglia in adult mouse,” Cell J., 15, 
212-217 (201).
22 Y. Cheng, N. X. Cawley, and Y. P. Loh, “Carboxypeptidase 
E/NFα1: a new neurotrophic factor against oxidative stress-
induced apoptotic cell death mediated by ERK and PI3-K/AKT 
pathways,” PLoS One, 8, e71578 (2013).
